National Cancer Institute / National Cancer Institute of Canada / /
IndustryTerm
given site / cancer therapy / treatment of cancer / study products / immuno-oncology investigational products / /
MedicalCondition
cancers / Combination Therapies Tumor / tumor / foreign cancer / Solid Tumours / cancer / tumors / disease / HBV / appropriate cancer / metastasis / HPV / systemic inflammatory reaction / solid tumors / resistant tumors / therapeutic cancer / newer cancer / hepatitis B / J Cancer / sarcoma / minimally symptomatic metastatic castrate-resistant prostate cancer / melanoma / renal cancer / stable disease / This inflammatory response / prostate cancer / metastases / directly killing cancer / primary tumors / /
MedicalTreatment
chemotherapy / immunotherapy / chemotherapies / cancer therapy / /
Organization
RECIST / World Health Organization / FDA / European Organization for Research and Treatment of Cancer / National Cancer Institute of Canada / National Cancer Institute of the United States / /
Person
Trials Sharon Moore / Ann Oncol / William Coley / /
Position
Chief Medical Officer / physician / representative / /
Product
Anticancer Drug / /
Technology
pharmacokinetics / immunotherapeutics / antibodies / chemotherapy / treating cancer / Drug Development / /
Understanding Immuno-oncology Trials Sharon Moore, MD, Chief Medical Officer, Chiltern The immune system is a very finely tuned system and is designed to protect the body against attack from pathogens, including viruses,